Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: A survey of the AAHKS membership

Journal of Arthroplasty

Volumn 16, Issue 6, 2001, Pages 679-688

  Mesko, J Wesley ^a   Brand, Richard A ^b   Iorio, Richard ^c   Gradisar, Ivan ^d   Heekin, Richard ^d   Leighton, Ross ^d   Thornberry, Robert ^e  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d Tallahassee Orthopaedic Clinic ^*  (Canada)

^e Tallahassee Orthopedic Clinic   (United States)

Author keywords

AAHKS; Prophylaxis; Total hip arthroplasty; Total knee arthroplasty; Venous thromboembolic disease

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; DEVICE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PROPHYLAXIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VEIN THROMBOSIS;

EID: 0034876144     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1054/arth.2001.25506     Document Type: Article

References (28)

1. Antithrombotic practice in orthopedic surgery: Results of a survey
2. Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery
3. Venous thrombosis prophylaxis, a survey of its use in the United States
4. Prevention of venous thromboembolism in North America: Results of a survey among general surgeons
5. Prevention of venous thrombosis
6. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis
7. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty
8. Hip arthroplasty: Postoperative management problems: A global approach to management in total hip and knee arthroplasty
9. Comparison of enoxaparin and warfarin for the prevention of venous thrombotic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge
10. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement
11. Prevention of deep-vein thrombosis after total hip arthroplasty
12. Metaanalysis of thromboembolic prophylaxis after total knee arthroplasty
13. Low molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
14. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement: A double-blind, dose-ranging study
15. Prevention of deep vein thrombosis after major knee surgery - A randomized, double blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo
16. Prevention of venous thromboembolism after knee arthroplasty
17. Enoxaparin a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery
18. Prophylaxis against deep-venous thrombosis following total hip replacement: Wither prophylaxis after total hip replacement
19. Complications after total hip arthroplasty: Results of the American Association of Hip and Knee surgeons (AAHKS) survey
20. Are recommendations for the routine use of pharmacological thromboprophylaxis in total hip arthroplasty justified?
21. Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis
22. Risks and benefits of prophylaxis against venous thromboembolism in orthopedic surgery
23. Pharmacological thromboprophylaxis and total hip replacement
24. Editorial: Thromboprophylaxis - Which treatment for which patient?
25. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement
26. The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement
27. Death and thromboembolic disease after total hip replacement
28. Cost analysis of extended prophylaxis with enoxaparin after hip arthroplasty